Alzheon, a privately-held clinical-stage biopharma company, presented promising Phase III APOLLOE4 trial results for ALZ-801 ...

Israel-based Teva Pharmaceuticals industries (NYSE: TEVA) today revealed two important updates reflecting its commitment to ...

Belgium’s influential biopharma industry is showing signs of strain for the first time in years, with both employment and ...

Italy-based Angelini Ventures, the corporate venture arm of Angelini Industries, has named Regina Hodits as managing director ...

South Korean clinical-stage biotech ABL Bio (Kosdaq: 298380) on Sunday announced a worldwide licensing agreement enabling GSK ...

French pharma major Sanofi and investment firm Cathay Capital have launched a $275 million fund that will invest in ...

German biotech Ethris, a company developing RNA therapeutics and vaccines, and Swiss contract development and manufacturing ...

China-based biotech DualityBio has named Hua Mu as its global chief medical officer, as the company prepares to ramp up its ...

Thousands of workers dismissed from the US Department of Health and Human Services this week may soon be reinstated, after ...

Australia’s Therapeutic Goods Administration (TGA) has accepted a court-enforceable undertaking from Your Solution ...

UK-based developer of novel immunoglobulin E (IgE) antibodies to treat cancer, Epsilogen, says it has completed the ...

The European Commission (EC) has approved an indication extension of Darzalex (daratumumab) subcutaneous (SC) formulation in ...